Claudio Bonifati
0000-0001-7752-4337
4 papers found
Refreshing results…
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Risankizumab for the treatment of moderate‐to‐severe psoriasis: A multicenter, retrospective, 1 year real‐life study
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy
Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study
Missing publications? Search for publications with a matching author name.